FibroBiologics, Inc. (FBLG)
↓ Download CSVKey ratios (FY2025)
-302.9%
Return on equity
| Metric (FY) | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating Income | -$16.65M | -$13.74M | -$8.89M | -$4.47M | — |
| Net Income | -$18.65M | -$11.16M | -$16.48M | -$5.12M | — |
| EPS (Diluted) | $-0.42 | $-0.34 | $-0.68 | $-0.18 | — |
| Total Assets | $9.62M | $16.45M | $11.82M | $4.82M | — |
| Total Liabilities | $3.46M | $13.71M | $10.57M | $8.82M | — |
| Shareholders' Equity | $6.16M | $2.73M | $1.25M | -$4.00M | -$1.29M |
| Cash & Equivalents | $4.89M | $13.98M | $9.16M | $2.27M | — |
| Operating Cash Flow | -$16.39M | -$11.90M | -$6.40M | -$4.07M | — |
| Capital Expenditures | $262.0K | $184.0K | $495.0K | — | — |
| Shares Outstanding | 44.66M | 32.88M | 28.23M | 28.23M | — |